A failed in-vitro control run is rarely just an assay problem. It is a documentation event. Before retesting, researchers should establish whether the material on the bench is a research peptide supplied for laboratory use or a licensed medicine with a different paper trail. The distinction is not academic. Research-use-onlyContinue Reading

For laboratory researchers and materials managers, the arrival of a batch is not simply a stock movement. It is a documentation event. The supplier’s description of solid-phase peptide synthesis (SPPS) manufacturing partners and UK release checks explains how a batch moves from an international synthesis partner into the UK supplyContinue Reading